The Global Fund / Le Fonds mondial
toggle menu
About Us
Our Partnership
Key Structures
Engage With Us
Topics
Replenishment
Our Financing
Results & Data
Impact Stories
Media Resources
News Releases
Opinion
Publication Categories
Resources
New Isoniazid/rifapentine and rifapentine generic for tuberculosis (TB) prevention recently recommended for use by ERP
20 May 2022
The following products have been recommended for use by the Expert Review Panel (ERP)
- Rifapentine 300mg tablets Al/Al strip pack manufactured by Lupin, India
- Rifapentine/Isoniazid 300/300mg Al/Al strip pack manufactured by Lupin, India
The recommendation is valid up to the 18th of May 2023.
For any PR procurement of the FPP recommended for use by ERP, The Global Fund will make the necessary arrangements for randomly selected samples of the FPP to be tested for quality control purposes prior to the delivery of that FPP by the manufacturer to the PR or other designated recipient.
The Global Fund uses cookies for anonymized statistics on website use and content performance to help us improve and adapt the website. To consent to the use of cookies, please click “Accept”. To learn more about your rights and options, please read our Privacy Statement.